These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19275037)

  • 41. Multimodal approach to treatment of neurological complications of chronic brain ischemia.
    Tanashyan MM; Shabalina AA; Lagoda OV; Raskurazhev AA; Konovalov RN
    Ter Arkh; 2018 Dec; 90(12):61-67. PubMed ID: 30701835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
    Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dissociation of the anti-amnesic and antihypoxic effects of nootropic and antihypoxic preparations].
    Voronina TA; Garibova TL; Khromova IV; Tilekeeva UM
    Farmakol Toksikol; 1987; 50(3):21-4. PubMed ID: 3609269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characteristics of the antihypoxic properties of 3-hydroxypyridine-class antioxidants].
    Tilekeeva UM; Voronina TA; Kuz'min VI; Sopyev DA; Aliev AN
    Farmakol Toksikol; 1987; 50(1):74-7. PubMed ID: 3556556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An evaluation of actovegin efficacy in bronchial asthma].
    Shafer AM; Abdusalamov AB; Komarin AS
    Klin Med (Mosk); 1995; 73(1):64. PubMed ID: 7791317
    [No Abstract]   [Full Text] [Related]  

  • 46. [The evaluation of the efficacy of antihypoxic agents lowering hemoglobin oxygen affinity in acute cerebral ischemia].
    Plotnikova TM; Plotnikov MB; Bazhenova TG
    Biull Eksp Biol Med; 1991 Feb; 111(2):170-2. PubMed ID: 1854961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome].
    Mychka VB; Chazova IE; Gornostaev VV; Sergienko VB
    Ter Arkh; 2005; 77(10):20-4. PubMed ID: 16320679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Neuroprotector therapy of patients with decompensated diabetes mellitus type 1].
    Kligunenko EN; Sedinkin VA
    Eksp Klin Farmakol; 2011; 74(12):15-8. PubMed ID: 22379876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
    Wu SX; Cui TT; Zhao C; Pan JJ; Xu BY; Tian Y; Cui NJ
    Radiother Oncol; 2010 Oct; 97(1):113-8. PubMed ID: 20826029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The physiological mechanisms of the antihypoxic action of the liposomes].
    Pozharov VP; Miniaĭlenko TD; Stefanov AV; Bryginskiĭ SA; Seredenko MM; Lishko VK
    Fiziol Zh SSSR Im I M Sechenova; 1990 Jul; 76(7):897-902. PubMed ID: 2174384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of antihypoxic and antiamnemonic effects of mexicor in animals].
    Iasnetsov VV; Karsanova SK; Ivanov IuV
    Aviakosm Ekolog Med; 2009; 43(6):31-6. PubMed ID: 20169737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Actovegin therapy of plexus-brachialis paresis following x-ray treatment].
    Gruia D; Bayerl JR
    Fortschr Med; 1981 Feb; 99(5):161-2. PubMed ID: 6268499
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antihypoxic and antioxidative properties of bemitil].
    Plotnikov MB; Saratikov AS; Plotnikova TM; Khazanov VA; Panina OP
    Biull Eksp Biol Med; 1989 May; 107(5):583-5. PubMed ID: 2736293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Actovegin in the treatment of brain injuries of mild and moderate severity].
    Talypov AE; Ioffe IuS; Miatchin MIu; Kuksova NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):20-3. PubMed ID: 18833103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of antioxidants and antihypoxants on the myoglobin content in patients with acute myocardial infarct].
    Shekhunova IA
    Vrach Delo; 1990 Sep; (9):10-2. PubMed ID: 2284744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No effect of intravenous Actovegin® on peak aerobic capacity.
    Lee P; Nokes L; Smith PM
    Int J Sports Med; 2012 Apr; 33(4):305-9. PubMed ID: 22318562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characteristics of the oxygen-transport function of the erythrocytes in acute altitude hypoxia].
    Filev LV; Mazurov VI; Enokhin SF; Korotkov DI
    Voen Med Zh; 1989 Oct; (10):39-42. PubMed ID: 2617893
    [No Abstract]   [Full Text] [Related]  

  • 59. [The use of actovegin in peptic ulcer].
    Nykula TD; Shevchuk SH; Moĭseienko VO; Kazimka LO
    Lik Sprava; 1993 Sep; (9):94-6. PubMed ID: 8085361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Drug rehabilitation in stroke patients].
    Skoromets AA; Koval'chuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):21-4. PubMed ID: 18379517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.